MedTrace Logo

Comparison Of Efficacy Of Combination Of TAM Formula Vs Kligman Formula For Melasma.

NCT06013540 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 122

Last updated 2023-08-28

No results posted yet for this study

Summary

This study would offer the participants about the knowledge of these formula in the treatment of melasma and help the investigators in incorporating and updating the management protocols in medical practice.

Conditions

  • Melasma

Interventions

COMBINATION_PRODUCT

TAM formula (hydroquinone 2%, tretinoin 0.05% and 5% vitamin C)

TAM formula (hydroquinone 2%, tretinoin 0.05% and 5% vitamin C)

COMBINATION_PRODUCT

Kligman formula (hydroquinone 4%, fluocinolone acetonide 0.01% and tretinoin 0.05%)

Kligman formula (hydroquinone 4%, fluocinolone acetonide 0.01% and tretinoin 0.05%)

Sponsors & Collaborators

  • Jinnah Postgraduate Medical Centre

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2022-12-01
Completion
2023-08-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06013540 on ClinicalTrials.gov